News

Pressrelease 2nd of June 2020 (for immediate publication)

In strong competition GAEU’s client Vicore Pharma Holding AB (publ) was awarded £ 1.5 million by the British charity LifeArc for a COVID-19 Phase II study with the drug candidate VP01. The study, named ATTRACT (Angiotensin II Type Two Receptor Agonist COVID-19 Trial), is targeting hospitalized patients treated with basic respiratory care, but not yet on mechanical ventilation. In close cooperation between the GAEU’s and Vicore’s team, the winning application was written in record time. 

Half of Phase 1 money went to GAEU Consulting’s clients

As many as 25 of the total 53 EU applications granted to Swedish companies before the SME Instrument’s Phase 1 closed for good earlier this year were written by GAEU.

GAEU´s clients winners at the premiere of the EIC Accelerator Pilot

GAEU’s clients became the big winners at the premiere of the newly expanded EU grant program for the most innovative SME companies – EIC Accelerator Pilot Phase 2 (formerly the SME instrument).

SME Instrument: New record. GAEU wrote 12 granted applications

In Sweden, companies applying for the SME Instrument Phase 1 may be granted from either the EU Commission or the Swedish innovation agency Vinnova through so-called runner up funding.

Horizon 2020 trumps national public funding in Poland

If you´re a Polish entrepreneur in the innovation sector with experience only in national public funding, this article is for you! It clearly presents the Horizon 2020 advantage over national funding programmes available in Poland.

Cellink and Klaria receives €4,5 Million from the Horizon 2020 SME Instrument Phase 2

GAEU Consulting’s clients Cellink and Klaria receives €4,5 Million from the Horizon 2020 SME Instrument Phase 2

H2020 SME Instrument: New Phase 1 record by GAEU Consulting

In this year’s second Horizon 2020 SME Instrument Phase 1 call (cut-off 3rd of May), GAEU Consulting wrote eight approved applications (excl another three so called runner up-applications).

GAEU Consulting’s client CombiGene receives €3,3 milion from the Horizon 2020 SME Instrument

CombiGene was granted 3,3 million euro in the latest Phase 2 round in the HorizonCombiGene was granted 3,3 million euro in the latest Phase 2 round in the Horizon2020 SME Instrument programme. GAEU Consulting wrote the EU application andguided the research company through the application procedure.

GAEU Consulting’s clients TLA and Xzero receives €4 Million from the Horizon 2020 SME Instrument

In the latest call for the phase 2 of the SME Instrument GAEU Consulting wrote two of four approved applications for Swedish innovation companies. GAEU´s customers received a total of 4 million euro.